Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...
Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...
Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next ...
Zacks Investment Research on MSN
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, ...
Abstract: This article reports a highly sensitive fiber Bragg grating (FBG) temperature sensor system based on microwave-photonic interrogation and the enhanced Vernier effect. A low-coherent ...
Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...
Abstract: This paper delves into the output feedback sliding mode control (SMC) problems in a class of Interval Type-2 (IT2) fuzzy systems affected by sensor faults. Firstly, a Markovian chain is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback